MPM
CRL icon

MBB Public Markets’s Charles River Laboratories CRL Stock Holding History

MBB Public Markets’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,493
Closed -$227K – 137
2025
Q2 		$227K Sell
1,493
-394
-21% -$52.5K 0.02% 462
2025
Q1 		$284K Buy
+1,887
New +$316K 0.03% 509
2024
Q4 		– Sell
-1,440
Closed -$284K – 194
2024
Q3 		$284K Sell
1,440
-86,943
-98% -$18.1M 0.02% 482
2024
Q2 		$18.3M Buy
88,383
+7,736
+10% +$1.75M 0.37% 56
2024
Q1 		$21.9M Sell
80,647
-3,851
-5% -$920K 1.34% 21
2023
Q4 		$20M Buy
+84,498
New +$16.6M 1.23% 28

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MBB Public Markets's CRL Position: Q3 2025 in Review

MBB Public Markets sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 1,493 shares — an estimated $227K sold.

MBB Public Markets first reported a position in CRL in Q4 2023 and held it in 6 quarters. The position peaked at $21.9M in Q1 2024. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • MBB Public Markets reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 1,493 Charles River Laboratories shares in Q3 2025, an estimated $227K.
  • MBB Public Markets first reported a position in Charles River Laboratories in Q4 2023 and held it in 6 quarters.
  • MBB Public Markets's Charles River Laboratories position peaked at $21.9M in Q1 2024.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.